Sunday, November 3, 2024
- Advertisement -spot_img

TAG

biopharmaceutical company

Vyluma Announces Marketing Authorization Application Validation for the European Union

BRIDGEWATER, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company dedicated to advancing novel ophthalmic solutions for refractive errors, announced...

Latest news

- Advertisement -spot_img